Why the study?
Does oral anticoagulation prevent stroke in patients with left ventricular systolic dysfunction and sinus rhythm?
Does oral anticoagulation prevent stroke in patients with left ventricular systolic dysfunction and sinus rhythm?
This review highlights the increased risk of stroke shortly after systolic heart failure diagnosis and proposes a rationale for considering oral anticoagulation in patients with sinus rhythm.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for early OAC in new systolic HF with sinus rhythm; RCTs needed before any practice change.
Left ventricular (LV) systolic dysfunction and chronic systolic heart failure (HF) predispose to intraventricular thrombus formation and embolization resulting in stroke. Current guideline recommends the use of oral anticoagulants in patients with atrial fibrillation and history of previous thromboembolism. However, anticoagulant treatment in patients with LV systolic dysfunction with sinus rhythm and without history of previous thromboembolism is still on debate. Recent epidemiologic date has reported increased stroke rate in patients with systolic HF shortly after diagnosis. This review focuses on the possible causes of increased stroke rate shortly after the diagnosis of HF and subsequently suggests a rationale for the use of oral anticoagulant in these patient groups.
No takes yet. Share an insight, caveat, or question.
Sıvrı et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: